Abstract
Background
Type 2 diabetes exposes the body to a state of high blood sugar for a long time and causes varying degrees of hardening of the arteries, making it more prone to cardiovascular emergencies.
Objective
The aim of the study was to explore the risk factors of early arterial stiffness in patients with type 2 diabetes mellitus (T2DM).
Methods
A retrospective study was conducted on 316 T2DM patients without macroangiopathy in The First Hospital of Qinhuangdao. Early arterial stiffness was evaluated by brachial-ankle pulse wave velocity (baPWV).
Results
Ninety patients (28.5%) had baPWV≥1800cm/s. baPWV showed positive correlation with systolic blood pressure (r=0.456, p<0.001), diastolic blood pressure (r=0.133, p=0.018), urine albumin-creatinine ratio (UACR) (r=0.232, p<0.001), neutrophil lymphocyte ratio (NLR) (r=0.185, p=0.001), and visceral fat area (r=0.139, p=0.014). In multiple linear regression analysis, systolic blood pressure (β=6.240, p<0.001), UACR (β=3.805, p=0.019), NLR (β=43.722, p=0.013), and visceral fat area (β=0.778, p=0.030) were significant independent predictors for baPWV.
Conclusion
The decline of arterial elasticity was common in T2DM patients without macroangiopathy. Elevated blood pressure, microangiopathy, chronic inflammation, and visceral fat accumulation were the risk factors of early arterial stiffness in patients with T2DM.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author, [Chun-Ming Ma], upon reasonable request.
References
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59.
Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–506.
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.
Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881–90.
Yang Y, Yao JJ, Du JL, Bai R, Sun LP, Sun GH, et al. Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese. Diabetes Care. 2013;36(4):978–84.
Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25(3):359–64.
Li T, Wu XJ, Chen XM, Wang SB, Liu KD, Xing YQ. Ankle-brachial index and brachial-ankle pulse wave velocity are risk factors for ischemic stroke in patients with Type 2 diabetes. Neural Regen Res. 2017;12(11):1853–9.
Kim BH, Jang JS, Kwon YS, Kim JH, Kim IJ, Lee CW. High brachial ankle pulse wave velocity as a marker for predicting coronary artery stenosis in patients with type 2 diabetes. Endocrinol Metab (Seoul). 2018;33(1):88–96.
Ogawa O, Onuma T, Kubo S, Mitsuhashi N, Muramatsu C, Kawamori R. Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2003;2:10.
Kim HJ, Nam JS, Park JS, Cho M, Kim CS, Ahn CW, et al. Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients. Diabetes Res Clin Pract. 2009;85(1):30–4.
Lin CC, Li CI, Liu CS, Lin CH, Yang SY, Li TC. Prediction of all-cause and cardiovascular mortality using ankle-brachial index and brachial-ankle pulse wave velocity in patients with type 2 diabetes. Sci Rep. 2022;12(1):11053.
Chang LH, Lin HD, Kwok CF, Won JG, Chen HS, Chu CH, et al. The combination of the ankle brachial index and brachial ankle pulse wave velocity exhibits a superior association with outcomes in diabetic patients. Intern Med. 2014;53(21):2425–31.
Kim JM, Kim SS, Kim IJ, Kim JH, Kim BH, Kim MK, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study. Cardiovasc Diabetol. 2020;19(1):143.
Nakamura M, Yamashita T, Yajima J, Oikawa Y, Sagara K, Koike A, et al. Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease. Hypertens Res. 2010;33(10):1018–24.
Katakami N, Osonoi T, Takahara M, Saitou M, Matsuoka TA, Yamasaki Y, et al. Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients. Cardiovasc Diabetol. 2014;13:128.
Lou YM, Liao MQ, Wang CY, et al. Association between brachial-ankle pulse wave velocity and risk of type 2 diabetes mellitus: results from a cohort study. BMJ Open Diabetes Res Care. 2020;8(1):e001317. https://doi.org/10.1136/bmjdrc-2020-001317.
Liu X, Liu L, Wang R, Jia X, Liu B, Ma N, et al. Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes. Endocr Connect. 2021;10(6):599–606.
Association. DSoCM. Guidelines for prevention and treatment of type 2 diabetes in China. Chinese Journal of Diabetes. 2018;10(1):4–67.
Takashima N, Turin TC, Matsui K, Rumana N, Nakamura Y, Kadota A, et al. The relationship of brachial-ankle pulse wave velocity to future cardiovascular disease events in the general Japanese population: the Takashima Study. J Hum Hypertens. 2014;28(5):323–7.
Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values.” Eur Heart J. 2010;31(19):2338–50. https://doi.org/10.1093/eurheartj/ehq165.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327–38.
Jiang Y, Li Y, Shi K, Wang J, Qian WL, Yan WF, et al. The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study. Cardiovasc Diabetol. 2022;21(1):1.
Zhang X, Bai R, Zou L, Zong J, Qin Y, Wang Y. Brachial-ankle pulse wave velocity as a novel modality for detecting early diabetic nephropathy in type 2 diabetes patients. J Diabetes Res. 2021;2021:8862573.
Xu C, Li L, Shi J, Ji B, Zheng Q, Wang Y, et al. Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetes. J Diabetes. 2022;14(5):345–55.
Bartz SK, Caldas MC, Tomsa A, Krishnamurthy R, Bacha F. Urine albumin-to-creatinine ratio: a marker of early endothelial dysfunction in youth. J Clin Endocrinol Metab. 2015;100(9):3393–9.
Bruno RM, Penno G, Daniele G, Pucci L, Lucchesi D, Stea F, et al. Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia. 2012;55(6):1847–55.
Huang H, Jin J, Chen Y, Wang L, Zhong J, Chen Z, Xu L. Visceral fat might impact left ventricular remodeling through changes in arterial stiffness in type 2 diabetes: A cross-sectional study. Int J Cardiol. 2022;368:78–84. https://doi.org/10.1016/j.ijcard.2022.08.033.
Bouchi R, Minami I, Ohara N, Nakano Y, Nishitani R, Murakami M, et al. Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2015;3(1):e000081.
Bruckert E. Abdominal obesity: a health threat. Presse Med. 2008;37(10):1407–14.
Tabara Y, Takahashi Y, Setoh K, Kawaguchi T, Gotoh N, Terao C, et al. Synergistic association of elevated serum free fatty acid and glucose levels with large arterial stiffness in a general population: The Nagahama Study. Metabolism. 2016;65(1):66–72.
Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:2703518.
Wang H, Hu Y, Geng Y, Wu H, Chu Y, Liu R, et al. The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension. J Clin Hypertens (Greenwich). 2017;19(8):780–5.
Li Y, Chen X, Huang L, Lu J. Association between neutrophil-lymphocyte ratio and arterial stiffness in patients with acute coronary syndrome. Biosci Rep. 2019;39(5):BSR20190015. https://doi.org/10.1042/BSR20190015.
Wang RT, Zhang JR, Li Y, Liu T, Yu KJ. Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. J Diabetes Complications. 2015;29(2):245–9.
Park BJ, Shim JY, Lee HR, Lee JH, Jung DH, Kim HB, et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta. 2011;412(11–12):925–9.
Pan Y, Zhong S, Zhou K, Tian Z, Chen F, Liu Z, et al. Association between diabetes complications and the triglyceride-glucose index in hospitalized patients with type 2 diabetes. J Diabetes Res. 2021;2021:8757996.
Wang R, Liu XL, Jia XJ, Liu Y, Lu Q. One-hour post-load plasma glucose levels are associated with early arterial stiffness in subjects with different glucose tolerance. Diabetes Metab Syndr Obes. 2022;15:1537–42.
Wakasugi S, Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, et al. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):15.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent for publication
We declare that submitted manuscript does not contain previously published material, and are not under consideration for publication elsewhere. Each author has made an important scientific contribution to the study and is thoroughly familiar with the primary data. All authors listed have read the complete manuscript and have approved submission of the paper. The manuscript is truthful original work without fabrication, fraud, or plagiarism.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The present study showed that the decline of arterial elasticity was common in type 2 diabetes patients. Elevated blood pressure, microangiopathy, chronic inflammation, and visceral fat accumulation were the risk factors of early arterial stiffness in patients with type 2 diabetes.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, JH., Wang, R., Jia, XJ. et al. The risk factors of early arterial stiffness in type 2 diabetes without diabetic macroangiopathy. Int J Diabetes Dev Ctries (2023). https://doi.org/10.1007/s13410-023-01220-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13410-023-01220-5